New Therapies in Development for Osteoarthritis

The lack of treatments to prevent or slow the progression of osteoarthritis is an unmet medical need. Currently, a number of medications with unique mechanisms of action are in clinical trials for both pain reduction and to determine if they can slow the progression of the disease. This course will review a number of the medications that are currently in phase 2 and phase 3 clinical trials for the treatment of painful large joint arthritis. The proposed mechanism of action and the results of the clinical studies will be reviewed.

Learning Objectives

  • Summarize the results of studies of the new therapies in clinical development for osteoarthritis

Additional Information

AttachmentSize
PDF icon Slides and Disclosures28.74 MB
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
06/01/2021
Course expires: 
06/01/2022
Part of: 
Osteoarthritis Research Society International Track
Rating: 
0

image

Nancy E. Lane, MD

Distinguished Professor of Medicine, Rheumatology, and Aging Research
UC Davis
Hillsborough, California

Available Credit

  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.